In recent years, it has been shown that tau pathology can be initiated in WT mouse brain by stereotaxic injection of human brain-derived AD-tau, with subsequent formation of endogenous mouse tau pathology near the sites of injection and spreading to more distant brain regions over time (Guo et al., 2016; He et al., 2020). The gene discussed is MAPT; the disease is Alzheimer disease.